Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 Countries

World News: . []

NEW HAVEN Conn and FLORENCE Italy March 02 2017 GLOBE NEWSWIRE -- Menarini will be responsible for submitting regulatory applications and pursuing pricing approvals for Delafloxacin in the countries being licensed Currently, the comp anies e...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Thursday 2nd March 2017

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers